How a hostile bid reaches shareholders
A company’s executives run the business, but its shareholders own it. That separation gives an outside bidder a route around leaders who reject a sale: instead of negotiating with management, the bidder can make an offer directly to shareholders for their stock. This is called a tender offer. Each investor decides whether to sell, often weighing the proposed price against the shares’ value if the company remains independent.
If enough shareholders accept, the bidder can acquire a large ownership stake without the executives’ consent. But buying shares is not always the same as instantly taking control. The bidder may need enough voting power to shape the board—the group that oversees the company—or to complete a transaction under the relevant rules and the company’s governing documents.
The fight can move to the boardroom
Company leaders can argue that the offer undervalues the business, seek a better deal, or use permitted defenses to make a takeover harder. One common tactic is a shareholder rights plan, often called a poison pill: it can make a bidder’s accumulation of shares much more costly, giving the company time to negotiate or rally investors. A bidder may answer by asking shareholders to elect new directors who are more open to the sale. That contest for board seats is known as a proxy fight.
So a hostile takeover is not simply a buyer overruling a company. It is a contest over ownership and voting power, with shareholders’ choices at its center. The practical consequence is striking: leaders may oppose a sale, yet they cannot assume that opposition alone will keep the company out of other hands.
